Alfa Laval AB (publ) ALFA.ST
Composite 50/100; the shares have moved about 23% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Valuation ranks 29/100 — a moderate mark against it.
Quality ranks 64/100 — a moderate point in its favour. Momentum ranks 63/100 — a moderate point in its favour. Balance-sheet strength ranks 57/100 — a slight point in its favour.
Valuation ranks 29/100 — a moderate mark against it. Growth ranks 32/100 — a moderate mark against it.
What the company does Alfa Laval AB designs and markets heat transfer, separation, and fluid handling solutions across Energy, Food & Pharma, and Ocean sectors. Its portfolio includes heat exchangers, separators, pumps, and ballast water systems sold globally to energy, food, and industrial end-markets.
Key financials ROE 19.1%, ROA 7.5%, and ROCE 19.1% reflect solid capital efficiency. Gross, operating, and net margins are 36.3%, 16.2%, and 11.6%, respectively. Revenue grew 7.7% while EPS grew 0.7%, with forward P/E at 25.91x and PEG at 2.47.
Stock health Sideravia scores Quality 60.0 and Momentum 64.5, but Valuation is 32.5. Debt/Equity is 0.46 and interest coverage is 21.94x. The 1.6% dividend yield and 1.12 current ratio support financial resilience.
Price vs fair value The stock trades at a PREMIUM of 37.90% versus our fair-value estimate of 340.00 and at a discount of 7.15% versus the 12-month target of 586.53. - Trading at a premium to fair value despite strong ROE and margins (company data). - Zacks compares ALFVY to KBR on valuation, highlighting sector richness (Zacks). - Analyst target implies 7.15% upside from current price (analyst count 17.0). - Valuation percentile of 32.5/100 underscores stretched pricing (Sideravia).
Looking forward Forward P/E compression to 25.91x and modest EPS growth of 0.7% suggest limited near-term rerating unless orders accelerate. Execution in Energy and Ocean segments will be key to justifying current multiples.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-03, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.